Bolt Biotherapeutics Announces Initiation of BDC-1001 Clinical Trial in Patients [...]

Bolt Biotherapeutics Appoints Dr. Nils Lonberg to its Scientific Advisory [...]

Bolt Biotherapeutics Expands Scientific Advisory Board with Appointment of Dr. [...]

Bolt Biotherapeutics Presents Data At SITC Conference Showing Eradication of [...]

Bolt Strengthens Scientific Advisory Board Through Addition of Drs. Lawrence [...]

Randall Schatzman, Ph.D., joins Bolt Biotherapeutics as CEO and a [...]

Bolt Biotherapeutics Presents Preclinical Proof of Concept Data at American [...]

Bolt Biotherapeutics Completes $54 Million Series B Financing